RT Journal Article
SR Electronic
T1 Correction: <em>Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging study</em>
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP e121
OP e121
DO 10.1136/annrheumdis-2020-216980corr1
VO 79
IS 9
YR 2020
UL http://ard.bmj.com/content/79/9/e121.abstract
AB